Open original FDA record ↗Recall record
- FDA identifier
- Z-0734-2022
- Company in FDA record
- Philips Healthcare
- FDA record creation date
- Mar 23, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
In the Azurion system, the user can add a new study to a patient by selecting the option "Add Study". The Add Study dialogue box is then displayed where the Patient Type is selected to perform the study. Due to a software defect, when the study is initiated by pressing Start Procedure , the Patient Type changes inadvertently to a Patient Type different than the one selected as shown in the Table below. Patient type is one of the factors involved in the dose control process. The incorrect patient type changes the technique factors to be used by the system without notification to the user.
Source facts
- Action
- Philips notified customers of the issue via an Electronic Product Radiation Defect notification letter dated February 8, 2022. Philips Field Service Engineers will schedule an appointment with customers to install the software update. Philips will correct the affected systems at no cost to customers with a software upgrade. For information, contact your local Philips representative: 1-800-722-9377.
- Initiated
- 2021-05-26
- Root cause
- Radiation Control for Health and Safety Act
- Distribution
- US Nationwide Distribution
- Recall number
- Z-0734-2022
- Recall status
- Completed
- CDRH record ID
- 192337
- FDA record created
- 2022-03-23
- Recall event number
- 89742